Medicare Enrolled
Dr. Dale Prokupek, MD
Gastroenterology · Beverly Hills, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Prokupek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Prokupek?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Prokupek
Dr. Dale Prokupek is a gastroenterology specialist in Beverly Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Prokupek performed 51,048 Medicare services across 1,072 unique beneficiaries.
Between the years covered by Open Payments, Dr. Prokupek received a total of $20,915 from 71 pharmaceutical and/or device companies across 1037 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Prokupek is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 0% volume in CA
$20,915 industry payments
Medicare Practice Summary
Medicare Utilization ↗51,048
Medicare services
Top 0% in CA for gastroenterology
1,072
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,687 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
48,041 | $36 | $126 |
| Online digital E/M service, established patient, 21+ minutes An online digital evaluation and management service for an established patient. This service requires a total time of 21 or more minutes over a period of up to 7 days. |
1,072 | $37 | $55 |
| Online digital evaluation and management service, nonphysician professional An online digital evaluation and management service provided by a nonphysician professional for up to 7 days, requiring at least 21 minutes of total time. |
565 | $26 | $45 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
464 | $150 | $210 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
171 | $102 | $145 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
163 | $59 | $240 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
113 | $77 | $115 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
100 | $12 | $75 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
92 | $13 | $75 |
| Anoscopy A diagnostic exam of the anus using a thin, lighted tube called an endoscope to look inside. |
91 | $109 | $150 |
| New patient office visit, complex (60-74 min) | 54 | $174 | $300 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
44 | $108 | $850 |
| Removal of bowel growth A surgical procedure to remove a growth from the small or large intestine. |
31 | $668 | $856 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
22 | $58 | $600 |
| Esophageal growth removal through neck Surgical removal of a growth from the esophagus via an incision in the neck. |
14 | $541 | $720 |
| Substance misuse assessment and intervention, over 30 minutes A structured evaluation and intervention for alcohol or substance misuse lasting more than 30 minutes. This service includes tools like the AUDIT or DAST to assess misuse and provide counseling. |
11 | $56 | $82 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
94.4% high complexity
0.3% medium
5.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$20,915
Total received (2018-2024)
Avg $2,988/year across 7 years
Top 11% in CA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
1,037
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,467 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$353 (1.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$94 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,674
2023
$3,311
2022
$2,860
2021
$2,616
2020
$2,408
2019
$2,860
2018
$3,185
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ViiV Healthcare Company
$1,271
Gilead Sciences, Inc.
$407
Janssen Biotech, Inc.
$334
Takeda Pharmaceuticals U.S.A., Inc.
$280
Merck Sharp & Dohme LLC
$249
Novo Nordisk Inc
$136
IRONSHORE PHARMACEUTICALS INC.
$121
EMD Serono, Inc.
$109
Novartis Pharmaceuticals Corporation
$104
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$97
Theratechnologies Inc.
$96
Napo Pharmaceuticals Inc
$77
ABBVIE INC.
$66
Phathom Pharmaceuticals, Inc.
$54
Lilly USA, LLC
$49
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$46
Alnylam Pharmaceuticals Inc.
$33
Verity Pharmaceuticals Inc.
$31
Bayer Healthcare Pharmaceuticals Inc.
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
Intercept Pharmaceuticals, Inc.
$22
IDORSIA PHARMACEUTICALS US INC
$20
Kestra Medical Technology Services, Inc.
$16
Top 3 companies account for 54.8% of 2024 payments
All-time payments by company (2018-2024) ›
ViiV Healthcare Company
$4,746
Gilead Sciences, Inc.
$2,749
Takeda Pharmaceuticals U.S.A., Inc.
$1,946
Janssen Biotech, Inc.
$1,290
Novo Nordisk Inc
$927
EMD Serono, Inc.
$862
Napo Pharmaceuticals Inc
$613
Merck Sharp & Dohme Corporation
$496
ABBVIE INC.
$496
Merck Sharp & Dohme LLC
$425
QOL Medical, LLC
$402
AbbVie, Inc.
$389
Amgen Inc.
$360
Lilly USA, LLC
$338
Theratechnologies Inc.
$325
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$323
AbbVie Inc.
$266
Janssen Pharmaceuticals, Inc
$204
Romark Laboratories, LC
$195
Antares Pharma, Inc.
$193
Allergan Inc.
$170
Concordia Pharmaceuticals Inc.
$155
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$155
Novartis Pharmaceuticals Corporation
$150
PFIZER INC.
$149
Nestle HealthCare Nutrition Inc.
$147
Bayer HealthCare Pharmaceuticals Inc.
$146
Neos Therapeutics, LP
$133
Intercept Pharmaceuticals, Inc.
$130
IRONSHORE PHARMACEUTICALS INC.
$121
Alnylam Pharmaceuticals Inc.
$119
Braintree Laboratories, Inc.
$119
IDORSIA PHARMACEUTICALS US INC
$97
Biohaven Pharmaceutical Holding Company Ltd.
$93
Janssen Scientific Affairs, LLC
$87
Shield Therapeutics Inc
$86
Boehringer Ingelheim Pharmaceuticals, Inc.
$77
Tris Pharma Inc
$74
GENZYME CORPORATION
$69
Synergy Pharmaceuticals Inc
$63
Eisai Inc.
$62
Shionogi Inc
$55
Phathom Pharmaceuticals, Inc.
$54
Bayer Healthcare Pharmaceuticals Inc.
$54
Kowa Pharmaceuticals America, Inc.
$52
Kestra Medical Technology Services, Inc.
$48
Baxter Healthcare
$46
Ironshore Pharmaceuticals Inc.
$46
Janssen Products, LP
$45
Supernus Pharmaceuticals, Inc.
$45
Kiniksa Pharmaceuticals, Ltd.
$44
Palette Life Sciences, Inc.
$44
Celgene Corporation
$35
Axsome Therapeutics, Inc.
$32
Verity Pharmaceuticals Inc.
$31
NESTLE HEALTHCARE NUTRITION INC.
$30
INSYS Therapeutics Inc
$29
AstraZeneca Pharmaceuticals LP
$26
Almatica Pharma LLC
$25
Shire North American Group Inc
$24
Melinta Therapeutics, LLC
$24
Allergan, Inc.
$23
IRONWOOD PHARMACEUTICALS, INC
$21
Actelion Pharmaceuticals US, Inc.
$21
Boston Scientific Corporation
$20
Nabriva Therapeutics, plc
$20
Melinta Therapeutics, Inc.
$20
GlaxoSmithKline, LLC.
$16
Aytu BioPharma, Inc.
$16
Acerus Pharmaceuticals Corporation
$16
Apollo Endosurgery US Inc
$5
Top 3 companies account for 45.1% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AMVUTTRA · APRETUDE · Adzenys XR-ODT · Alinia · Alinia Tablets 500mg 30 count bottle · Assure WCD · BREO · Biktarvy · CABENUVA · CHANTIX · COLOGUARD · CREON · Corlanor · Creon · DELSTRIGO · DIFICID · DONNATAL · DOVATO · DUPIXENT · Dayvigo · Descovy · Donnatal · Dyanavel XR · EGRIFTA · ENTRESTO · ENTYVIO · Entyvio · GRALISE · HUMIRA · Humira · ISENTRESS · JARDIANCE · JORNAY PM · JULUCA · Kerendia · Kimyrsa · LEQVIO · LINZESS · LUCEMYRA · LUX-Dx Insertable Cardiac Monitor · LifeVest · Linzess · Livalo · MAVYRET · MOTEGRITY · MOTOFEN · MOUNJARO · MOVANTIK · Mavyret · Motegrity · Mytesi · NOCDURNA · NURTEC ODT · Natesto · OCALIVA · ONPATTRO · OPSUMIT · OTREXUP · Orbactiv · Orbera · Otezla · Otrexup · Ozempic · PIFELTRO · PREZCOBIX · PREZISTA · QELBREE · QUVIVIQ · RINVOQ · RUKOBIA · RYBELSUS · Repatha · Rybelsus · SEROSTIM · SKYRIZI · SOLESTA · STELARA · SUCRAID · SUPREP · SUPREP BOWEL PREP · SYMTUZA · SYNDROS · Saxenda · Serostim · Sucraid · Sunosi · Symproic · Symtuza · TISSEEL · TRADJENTA · TREMFYA · TRINTELLIX · TRIUMEQ · TROGARZO · TRULANCE · TRULICITY · Tlando · Tresiba · Trintellix · Trulance · Truvada · VERQUVO · VIBERZI · VOQUEZNA · VYNDAQEL · VYVANSE · Victoza · Vyvanse · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xenleta · ZENPEP · ZEPOSIA · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
475
Per 100K population
4.8
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.8 mi
0.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Prokupek is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with low-engagement industry engagement in the top 11% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Prokupek experienced with immune globulin infusion (gammagard)?
Based on Medicare claims data, Dr. Prokupek performed 48,041 immune globulin infusion (gammagard) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Prokupek receive payments from pharmaceutical companies?
Yes. Dr. Prokupek received a total of $20,915 from 71 companies across 1,037 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Prokupek's costs compare to other gastroenterologists in Beverly Hills?
Dr. Prokupek's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Prokupek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Beverly Hills
Browse gastroenterologists in Beverly Hills ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in CA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in CA
Which CA gastroenterologists receive the most from drug and device companies.
By company
ViiV Healthcare Company Payments to Doctors
See all physicians who received payments from ViiV Healthcare Company.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology